India, Feb. 28 -- Akero Therapeutics Inc. (AKRO) released Loss for fourth quarter that beat the Street estimates.
The company's earnings totaled -$70.03 million, or -$0.99 per share. This compares with -$55.2 million, or -$0.99 per share, last year.
Analysts on average had expected the company to earn -$1.12 per share. Analysts' estimates typically exclude special items.
Akero Therapeutics Inc. earnings at a glance (GAAP) :
-Earnings: -$70.03 Mln. vs. -$55.2 Mln. last year.-EPS: -$0.99 vs. -$0.99 last year.
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Services with permission from RTT News....